{"id":50407,"date":"2020-07-31T03:00:38","date_gmt":"2020-07-31T01:00:38","guid":{"rendered":"https:\/\/www.cde.ual.es\/?p=50407"},"modified":"2020-07-30T11:59:57","modified_gmt":"2020-07-30T09:59:57","slug":"remdesivir-european-commission-guarantees-access","status":"publish","type":"post","link":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/","title":{"rendered":"Remdesivir: European Commission guarantees access"},"content":{"rendered":"<p>On 28th July the European Commission signed a contract with the <strong>pharmaceutical company Gilead to guarantee treatment doses of Veklury<\/strong>, which is the trade name of remdesivir.<\/p>\n<p><a href=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png\"><img decoding=\"async\" class=\"size-medium wp-image-16452 aligncenter\" src=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion-300x189.png\" alt=\"\" width=\"300\" height=\"189\" srcset=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion-300x189.png 300w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion-768x485.png 768w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png 927w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p>Veklury was the first drug authorised on an EU level for the treatment of COVID-19. From early August, batches of Veklury will be made available to Member States and the UK, with coordination and support from the Commission, to meet immediate needs.<\/p>\n<h3>How it will be financed<\/h3>\n<p>The Commission&#8217;s Emergency Assistance Instrument will finance the contract, for a total amount of EUR 63 million. 63 million. This will ensure the treatment of 30 000 patients with severe symptoms of COVID-19. This will help to cover current needs over the coming months and at the same time ensure a fair distribution at EU level, based on a distribution key, with the advice of the European Centre for Disease Prevention and Control.<\/p>\n<p>The Commission is also currently preparing a joint procurement for new supplies of the medicine, which is expected to cover additional needs and supplies from October.<\/p>\n<h3>More information<\/h3>\n<p><a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/IP_20_1416\">Press release &#8211; European Commission<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 28th July the European Commission signed a contract with the pharmaceutical company Gilead to guarantee treatment doses of Veklury, which is the trade name of remdesivir. Veklury was the first drug authorised on an EU level for the treatment of COVID-19. From early August, batches of Veklury will be made available to Member States [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":16452,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[4093,346,4094,4092],"tags":[1322,437],"class_list":{"0":"post-50407","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-diseases","8":"category-eu-news","9":"category-farmac","10":"category-health","11":"tag-coronavirus-en","12":"tag-health","13":"entry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Remdesivir: European Commission guarantees access | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Remdesivir: European Commission guarantees access | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"og:description\" content=\"On 28th July the European Commission signed a contract with the pharmaceutical company Gilead to guarantee treatment doses of Veklury, which is the trade name of remdesivir. Veklury was the first drug authorised on an EU level for the treatment of COVID-19. From early August, batches of Veklury will be made available to Member States [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/\" \/>\n<meta property=\"og:site_name\" content=\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-31T01:00:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png\" \/>\n\t<meta property=\"og:image:width\" content=\"927\" \/>\n\t<meta property=\"og:image:height\" content=\"585\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"AdminCDE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:site\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"AdminCDE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/\"},\"author\":{\"name\":\"AdminCDE\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/224ef08c8bcc005f319d2713ce37ee5f\"},\"headline\":\"Remdesivir: European Commission guarantees access\",\"datePublished\":\"2020-07-31T01:00:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/\"},\"wordCount\":182,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"keywords\":[\"Coronavirus\",\"health\"],\"articleSection\":[\"Diseases\",\"EU News\",\"Farmaceutical\",\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/\",\"name\":\"Remdesivir: European Commission guarantees access | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"datePublished\":\"2020-07-31T01:00:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2018\\\/12\\\/Vacunacion.png\",\"width\":927,\"height\":585},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/remdesivir-european-commission-guarantees-access\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU News\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Health\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/health\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Diseases\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/health\\\/diseases\\\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"Remdesivir: European Commission guarantees access\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"name\":\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"description\":\"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"alternateName\":\"CDE Almer\u00eda\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cde.ual.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\",\"name\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"width\":1400,\"height\":300,\"caption\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cdeuniversidadalmeria\\\/\",\"https:\\\/\\\/x.com\\\/cdeualmeria\",\"https:\\\/\\\/www.tiktok.com\\\/@cdealmeria\",\"https:\\\/\\\/www.instagram.com\\\/cdealmeria\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/cde-almera-812b26a9\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/224ef08c8bcc005f319d2713ce37ee5f\",\"name\":\"AdminCDE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g\",\"caption\":\"AdminCDE\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Remdesivir: European Commission guarantees access | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/","og_locale":"en_US","og_type":"article","og_title":"Remdesivir: European Commission guarantees access | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","og_description":"On 28th July the European Commission signed a contract with the pharmaceutical company Gilead to guarantee treatment doses of Veklury, which is the trade name of remdesivir. Veklury was the first drug authorised on an EU level for the treatment of COVID-19. From early August, batches of Veklury will be made available to Member States [&hellip;]","og_url":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/","og_site_name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","article_publisher":"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","article_published_time":"2020-07-31T01:00:38+00:00","og_image":[{"width":927,"height":585,"url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","type":"image\/png"}],"author":"AdminCDE","twitter_card":"summary_large_image","twitter_creator":"@cdeualmeria","twitter_site":"@cdeualmeria","twitter_misc":{"Written by":"AdminCDE","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/#article","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/"},"author":{"name":"AdminCDE","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/224ef08c8bcc005f319d2713ce37ee5f"},"headline":"Remdesivir: European Commission guarantees access","datePublished":"2020-07-31T01:00:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/"},"wordCount":182,"commentCount":0,"publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","keywords":["Coronavirus","health"],"articleSection":["Diseases","EU News","Farmaceutical","Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/","url":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/","name":"Remdesivir: European Commission guarantees access | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/#primaryimage"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","datePublished":"2020-07-31T01:00:38+00:00","breadcrumb":{"@id":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/#primaryimage","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2018\/12\/Vacunacion.png","width":927,"height":585},{"@type":"BreadcrumbList","@id":"https:\/\/www.cde.ual.es\/en\/remdesivir-european-commission-guarantees-access\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.cde.ual.es\/en\/"},{"@type":"ListItem","position":2,"name":"EU News","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/"},{"@type":"ListItem","position":3,"name":"Health","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/health\/"},{"@type":"ListItem","position":4,"name":"Diseases","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/health\/diseases\/"},{"@type":"ListItem","position":5,"name":"Remdesivir: European Commission guarantees access"}]},{"@type":"WebSite","@id":"https:\/\/www.cde.ual.es\/#website","url":"https:\/\/www.cde.ual.es\/","name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","description":"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda","publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"alternateName":"CDE Almer\u00eda","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cde.ual.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cde.ual.es\/#organization","name":"Centro de Documentaci\u00f3n Europea de Almer\u00eda","url":"https:\/\/www.cde.ual.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","width":1400,"height":300,"caption":"Centro de Documentaci\u00f3n Europea de Almer\u00eda"},"image":{"@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","https:\/\/x.com\/cdeualmeria","https:\/\/www.tiktok.com\/@cdealmeria","https:\/\/www.instagram.com\/cdealmeria\/","https:\/\/www.linkedin.com\/in\/cde-almera-812b26a9\/"]},{"@type":"Person","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/224ef08c8bcc005f319d2713ce37ee5f","name":"AdminCDE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a72d038d371f995cd13706fac32274b7952a52e8fb0a84b5f80c85426f2a98a8?s=96&d=mm&r=g","caption":"AdminCDE"}}]}},"_links":{"self":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/50407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/comments?post=50407"}],"version-history":[{"count":0,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/50407\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media\/16452"}],"wp:attachment":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media?parent=50407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/categories?post=50407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/tags?post=50407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}